John McGrath, DO
Otolaryngology · Philadelphia, PANPI 1659328086
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (31.4%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Optinose US, Inc. at 48.1% of the total. Reporting peaked in 2020 at $4,218 and has fallen 58.8% since, to $1,738 in 2025. Among otolaryngology clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 113 payments — averaging $84.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optinose US, Inc.$5K
- Sanofi$3K
- Intersect ENT, Inc.$359
- Regeneron Healthcare Solutions, Inc.$243
- Kaleo, Inc.$241
- Integra Lifesciences Corporation$173
- plus $504 from 9 others
What the payments were for
- Consulting fees$2,84930%
- Speaking & faculty fees$2,50026%
- Travel & lodging$1,06011%
- Food & beverage$2,98731%
- Education$1081%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optinose US, Inc. | 29 | $4,572 |
| Sanofi | 38 | $3,412 |
| Intersect ENT, Inc. | 6 | $359 |
| Regeneron Healthcare Solutions, Inc. | 11 | $243 |
| Kaleo, Inc. | 16 | $241 |
| Integra Lifesciences Corporation | 1 | $173 |
| Medtronic | 1 | $150 |
| Stryker | 2 | $123 |
| Sanofi-aventis U.S. LLC | 2 | $108 |
| Acclarent, Inc | 2 | $37 |
| Alk-abello, Inc | 1 | $26 |
| Arbor Pharmaceuticals, Inc. | 1 | $18 |
| Aerin Medical Inc. | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
| Hikma Pharmaceuticals USA | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Xhance$4,253
- DUPIXENT$1,547
- PROPEL$228
- Acclarent Aera$173
- Inspira Air$173
- RELIEVA SPINPLUS NAV$173
- TruDi Probe$173
How this compares
$9,504 in reported general payments places this provider in the 90th percentile of 456 otolaryngology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 12 | $52,245 |
| Ipratropium Bromide | 141 | $5,324 |
| Famotidine | 234 | $3,793 |
| Fluticasone Propionate | 174 | $3,494 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 21 | $2,252 |
| Fluocinolone Acetonide Oil | 30 | $1,382 |
| Omeprazole | 99 | $1,026 |
| Cefdinir | 64 | $1,011 |
| Montelukast Sodium | 67 | $995 |
| Azelastine Hcl | 21 | $898 |
| Pantoprazole Sodium | 59 | $624 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 16 | $491 |
| Mometasone Furoate | 13 | $303 |
| Methylprednisolone | 49 | $248 |
| Ofloxacin | 14 | $240 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Philadelphia
- Nancy SnydermanPhiladelphia$4.5M
- David KennedyPhiladelphia$603K
- James PalmerPhiladelphia$331K
- Mathew NagorskyPhiladelphia$95K
- Noam CohenPhiladelphia$76K
- Nithin AdappaPhiladelphia$72K
- Steven CannadyPhiladelphia$33K
- David CognettiPhiladelphia$30K
- John KrousePhiladelphia$30K
- Soo AbboudPhiladelphia$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.